Status:
COMPLETED
A Study on the Feasibility and Acceptability of Pericoital Levonorgestrel 1.5mg
Lead Sponsor:
Camber Collective
Collaborating Sponsors:
Population Council
Marie Stopes International
Conditions:
Pregnancy Related
Eligibility:
FEMALE
18-49 years
Brief Summary
This study intends to build on the previous research and gather data in an actual use study / patient registry of pericoital LNG 1.5mg to understand women's acceptability of the product along with ass...
Detailed Description
The study would consist of distributing pericoital LNG 1.5mg across 75 pharmacy sites in Ghana over the course of 12 months. Recruitment will be staggered, and women will be recruited up to 9 months i...
Eligibility Criteria
Inclusion
- between the age of 18-49 years, is willing to use LNG 1.5 mg tablets as her primary contraceptive method, wants to avoid pregnancy for at least the next 6 months after enrollment, is willing to accept an uncertain risk of pregnancy during the study, and understands that the risk of pregnancy on this method would be slightly higher than other methods of contraception
Exclusion
- women using one or more of the following contraceptive methods: daily pill, injectable, implant, sterilization
Key Trial Info
Start Date :
October 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2020
Estimated Enrollment :
1980 Patients enrolled
Trial Details
Trial ID
NCT04058873
Start Date
October 1 2019
End Date
November 1 2020
Last Update
November 5 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Marie Stopes International Ghana
Accra, Ghana